{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:54:45Z","timestamp":1788483285588,"version":"build-2803163510"},"reference-count":134,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Cancer Care"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1111\/ecc.12787","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T07:47:05Z","timestamp":1508831225000},"page":"e12787","source":"Crossref","is-referenced-by-count":12,"title":["Antiresorptive treatment-associated ONJ"],"prefix":"10.1155","volume":"26","author":[{"given":"Evangelos","family":"Eleutherakis-Papaiakovou","sequence":"first","affiliation":[{"name":"Department of Clinical Therapeutics; National and Kapodistrian University of Athens; Athens Greece"},{"name":"Department of Clinical Therapeutics; Alexandra Hospital; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5996-7262","authenticated-orcid":false,"given":"Aristotelis","family":"Bamias","sequence":"additional","affiliation":[{"name":"Department of Clinical Therapeutics; National and Kapodistrian University of Athens; Athens Greece"},{"name":"Department of Clinical Therapeutics; Alexandra Hospital; Athens Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,24]]},"reference":[{"key":"10.1111\/ecc.12787-BIB0001|ecc12787-cit-0001","doi-asserted-by":"crossref","first-page":"971","DOI":"10.14219\/jada.archive.2007.0294","article-title":"The treatment of bisphosphonate-associated osteonecrosis of the jaws with bone resection and autologous platelet-derived growth factors","volume":"138","author":"Adornato","year":"2007","journal-title":"Journal of the American Dental Association"},{"key":"10.1111\/ecc.12787-BIB0002|ecc12787-cit-0002","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.joms.2009.10.010","article-title":"Osteonecrosis of the jaw in a patient on Denosumab","volume":"68","author":"Aghaloo","year":"2010","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0003|ecc12787-cit-0003","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1097\/scs.0b013e31857261f","article-title":"Ozone therapy in the treatment of avascular bisphosphonate-related jaw osteonecrosis","volume":"18","author":"Agrillo","year":"2007","journal-title":"The Journal of Craniofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0004|ecc12787-cit-0004","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jebdp.2012.03.003","article-title":"Risks for jaw osteonecrosis drastically increases after 2\u00a0years of bisphosphonate therapy","volume":"12","author":"Akintoye","year":"2012","journal-title":"The Journal of Evidence-Based Dental Practice"},{"key":"10.1111\/ecc.12787-BIB0005|ecc12787-cit-0005","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.jdent.2014.10.006","article-title":"Hyperbaric oxygen therapy accelerates osteoblast differentiation and promotes bone formation","volume":"43","author":"Al Hadi","year":"2015","journal-title":"Journal of Dentistry"},{"key":"10.1111\/ecc.12787-BIB0006|ecc12787-cit-0006","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1089\/pho.2014.3742","article-title":"Low-level laser therapy supported surgical treatment of bisphosphonate related osteonecrosis of jaws: A retrospective analysis of 11 cases","volume":"32","author":"Altay","year":"2014","journal-title":"Photomedicine and Laser Surgery"},{"key":"10.1111\/ecc.12787-BIB0007|ecc12787-cit-0007","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1038\/bcj.2012.9","article-title":"Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: A retrospective multicentric study","volume":"2","author":"Andriani","year":"2012","journal-title":"Blood Cancer Journal"},{"key":"10.1111\/ecc.12787-BIB0008|ecc12787-cit-0008","first-page":"3917","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in consideration of primary diseases and concomitant therapies","volume":"33","author":"Assaf","year":"2013","journal-title":"Anticancer Research"},{"key":"10.1111\/ecc.12787-BIB0009|ecc12787-cit-0009","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.jcms.2015.06.025","article-title":"Intraindividual comparison of preoperative (99\u00a0m)Tc-MDP SPECT\/CT and intraoperative and histopathological findings in patients with bisphosphonate- or denosumab-related osteonecrosis of the jaw","volume":"43","author":"Assaf","year":"2015","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0010|ecc12787-cit-0010","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/j.jcms.2013.07.014","article-title":"Intraoperative efficiency of fluorescence imaging by visually enhanced lesion scope (VELscope) in patients with bisphosphonate related osteonecrosis of the jaw (BRONJ)","volume":"42","author":"Assaf","year":"2014","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0011|ecc12787-cit-0011","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1600-0714.2004.00269.x","article-title":"Avascular jaw osteonecrosis in association with cancer chemotherapy: Series of 10 cases","volume":"34","author":"Bagan","year":"2005","journal-title":"Journal of Oral Pathology and Medicine"},{"key":"10.1111\/ecc.12787-BIB0012|ecc12787-cit-0012","doi-asserted-by":"crossref","first-page":"8580","DOI":"10.1200\/JCO.2005.02.8670","article-title":"Osteonecrosis of the jaw in cancer after treatment with bisphosphonates: Incidence and risk factors","volume":"23","author":"Bamias","year":"2005","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/ecc.12787-BIB0013|ecc12787-cit-0013","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00520-014-2267-3","article-title":"Low-level laser therapy for osteonecrotic lesions: Effects on osteoblasts treated with zoledronic acid","volume":"22","author":"Basso","year":"2014","journal-title":"Supportive Care in Cancer"},{"key":"10.1111\/ecc.12787-BIB0014|ecc12787-cit-0014","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.tripleo.2007.08.040","article-title":"Bisphosphonate-associated jawbone osteonecrosis: A correlation between imaging techniques and histopathology","volume":"105","author":"Bedogni","year":"2008","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics"},{"key":"10.1111\/ecc.12787-BIB0015|ecc12787-cit-0015","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1601-0825.2012.01903.x","article-title":"Learning from experience. Proposal of a refined definition and staging system for bisphosphonate-related osteonecrosis of the jaw (BRONJ)","volume":"18","author":"Bedogni","year":"2012","journal-title":"Oral Diseases"},{"key":"10.1111\/ecc.12787-BIB0016|ecc12787-cit-0016","first-page":"e43","article-title":"Analysis of different therapeutic protocols for osteonecrosis of the jaw associated with oral and intravenous bisphosphonates","volume":"22","author":"Bermudez-Bejarano","year":"2017","journal-title":"Medicina Oral, Patolog\u00eda Oral y Cirug\u00eda Bucal"},{"key":"10.1111\/ecc.12787-BIB0017|ecc12787-cit-0017","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s10006-016-0597-7","article-title":"Treatment of medication-related osteonecrosis of the jaws (MRONJ) with ultrasonic piezoelectric bone surgery. A case series of 20 treated sites","volume":"21","author":"Blus","year":"2017","journal-title":"Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0018|ecc12787-cit-0018","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2174\/1874210601307010094","article-title":"Use of ultrasonic bone surgery (Piezosurgery) to surgically treat bisphosphonate-related osteonecrosis of the jaws (BRONJ). A case series report with at least 1 year of follow-up","volume":"7","author":"Blus","year":"2013","journal-title":"The Open Dentistry Journal"},{"key":"10.1111\/ecc.12787-BIB0019|ecc12787-cit-0019","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jcms.2015.02.018","article-title":"Incidence of bisphosphonate-related osteonecrosis of the jaw in high-risk patients undergoing surgical tooth extraction","volume":"43","author":"Bodem","year":"2015","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0020|ecc12787-cit-0020","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jcms.2015.05.019","article-title":"Value of nonsurgical therapeutic management of stage I bisphosphonate-related osteonecrosis of the jaw","volume":"43","author":"Bodem","year":"2015","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0021|ecc12787-cit-0021","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.oooo.2015.10.033","article-title":"Surgical management of bisphosphonate-related osteonecrosis of the jaw stages II and III","volume":"121","author":"Bodem","year":"2016","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"key":"10.1111\/ecc.12787-BIB0022|ecc12787-cit-0022","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.archoralbio.2014.05.002","article-title":"Important aspects regarding the role of microorganisms in bisphosphonate-related osteonecrosis of the jaws","volume":"59","author":"Boff","year":"2014","journal-title":"Archives of Oral Biology"},{"key":"10.1111\/ecc.12787-BIB0023|ecc12787-cit-0023","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/clr.12556","article-title":"Denosumab and osteonecrosis of the jaw. A systematic analysis of events reported in clinical trials","volume":"27","author":"Boquete-Castro","year":"2016","journal-title":"Clinical Oral Implants Research"},{"key":"10.1111\/ecc.12787-BIB0024|ecc12787-cit-0024","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00774-014-0566-x","article-title":"Prospective, mono-institutional study of the impact of a systematic prevention program on incidence and outcome of osteonecrosis of the jaw in patients treated with bisphosphonates for bone metastases","volume":"33","author":"Bramati","year":"2015","journal-title":"Journal of Bone and Mineral Metabolism"},{"key":"10.1111\/ecc.12787-BIB0025|ecc12787-cit-0025","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1016\/j.clinthera.2011.10.008","article-title":"Denosumab for the reduction of bone loss in postmenopausal osteoporosis: A review","volume":"33","author":"Bridgeman","year":"2011","journal-title":"Clinical Therapeutics"},{"key":"10.1111\/ecc.12787-BIB0026|ecc12787-cit-0026","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/bcr413","article-title":"The present and future role of bisphosphonates in the management of patients with breast cancer","volume":"4","author":"Brown","year":"2002","journal-title":"Breast Cancer Research"},{"key":"10.1111\/ecc.12787-BIB0027|ecc12787-cit-0027","first-page":"89","article-title":"Role of denosumab in the management of skeletal complications in patients with bone metastases from solid tumors","volume":"6","author":"Brown-Glaberman","year":"2012","journal-title":"Biologics"},{"key":"10.1111\/ecc.12787-BIB0028|ecc12787-cit-0028","first-page":"35","article-title":"Adjuvant aqueous ozone in the treatment of bisphosphonate induced necrosis of the jaws: Report of two cases and long-term follow-up","volume":"63","author":"Brozoski","year":"2014","journal-title":"Minerva Stomatologica"},{"key":"10.1111\/ecc.12787-BIB0029|ecc12787-cit-0029","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3389\/fonc.2013.00329","article-title":"Effects of RANKL-targeted therapy in immunity and cancer","volume":"3","author":"Cheng","year":"2014","journal-title":"Front Oncology"},{"key":"10.1111\/ecc.12787-BIB0030|ecc12787-cit-0030","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1097\/SCS.0b013e31824dbdd4","article-title":"Recombinant human bone morphogenetic protein type 2 application for a possible treatment of bisphosphonates-related osteonecrosis of the jaw","volume":"23","author":"Cicciu","year":"2012","journal-title":"The Journal of Craniofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0031|ecc12787-cit-0031","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1056\/NEJMoa1105195","article-title":"Breast-cancer adjuvant therapy with zoledronic acid","volume":"365","author":"Coleman","year":"2011","journal-title":"New England Journal of Medicine"},{"key":"10.1111\/ecc.12787-BIB0032|ecc12787-cit-0032","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2165\/00003088-200544060-00001","article-title":"Pharmacokinetics\/pharmacodynamics of bisphosphonates: Use for optimisation of intermittent therapy for osteoporosis","volume":"44","author":"Cremers","year":"2005","journal-title":"Clinical Pharmacokinetics"},{"key":"10.1111\/ecc.12787-BIB0033|ecc12787-cit-0033","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s10096-014-2160-5","article-title":"Actinomyces osteomyelitis in bisphosphonate-related osteonecrosis of the jaw (BRONJ): The missing link?","volume":"33","author":"Ceulaer","year":"2014","journal-title":"European Journal of Clinical Microbiology and Infectious Diseases"},{"key":"10.1111\/ecc.12787-BIB0034|ecc12787-cit-0034","first-page":"2477","article-title":"Prevention of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates","volume":"34","author":"Luliis","year":"2014","journal-title":"Anticancer Research"},{"key":"10.1111\/ecc.12787-BIB0035|ecc12787-cit-0035","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ejca.2014.10.015","article-title":"Autologous platelet concentrates for bisphosphonate-related osteonecrosis of the jaw treatment and prevention. A systematic review of the literature","volume":"51","author":"Fabbro","year":"2015","journal-title":"European Journal of Cancer"},{"key":"10.1111\/ecc.12787-BIB0036|ecc12787-cit-0036","first-page":"961","article-title":"Clinical and histopathological studies using fibrin-rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw","volume":"55","author":"Dinca","year":"2014","journal-title":"Romanian Journal of Morphology and Embryology"},{"key":"10.1111\/ecc.12787-BIB0037|ecc12787-cit-0037","first-page":"222","article-title":"Teriparatide therapy for bisphosphonate-related osteonecrosis of the jaw associated with dental implants","volume":"24","author":"Doh","year":"2015","journal-title":"Implant Dentistry"},{"key":"10.1111\/ecc.12787-BIB0038|ecc12787-cit-0038","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1200\/JCO.2007.15.5424","article-title":"Osteonecrosis of the jaw related to bevacizumab","volume":"26","author":"Estilo","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/ecc.12787-BIB0039|ecc12787-cit-0039","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.bjoms.2014.09.001","article-title":"Up to a quarter of patients with osteonecrosis of the jaw associated with antiresorptive agents remain undiagnosed","volume":"53","author":"Fedele","year":"2015","journal-title":"The British Journal of Oral & Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0040|ecc12787-cit-0040","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.amjmed.2010.04.033","article-title":"Nonexposed variant of bisphosphonate-associated osteonecrosis of the jaw: A case series","volume":"123","author":"Fedele","year":"2010","journal-title":"American Journal of Medicine"},{"key":"10.1111\/ecc.12787-BIB0041|ecc12787-cit-0041","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1007\/s00432-010-0907-7","article-title":"Bisphosphonate-induced osteonecrosis of the jaw: A review of 2,400 patient cases","volume":"136","author":"Filleul","year":"2010","journal-title":"Journal of Cancer Research and Clinical Oncology"},{"key":"10.1111\/ecc.12787-BIB0042|ecc12787-cit-0042","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/edrv.19.1.0325","article-title":"Bisphosphonates: Mechanisms of action","volume":"19","author":"Fleisch","year":"1998","journal-title":"Endocrine Reviews"},{"key":"10.1111\/ecc.12787-BIB0043|ecc12787-cit-0043","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.joms.2015.10.025","article-title":"Does fluorodeoxyglucose positron emission tomography with computed tomography facilitate treatment of medication-related osteonecrosis of the jaw?","volume":"74","author":"Fleisher","year":"2016","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0044|ecc12787-cit-0044","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.joms.2014.04.017","article-title":"Fluorodeoxyglucose positron emission tomography with computed tomography detects greater metabolic changes that are not represented by plain radiography for patients with osteonecrosis of the jaw","volume":"72","author":"Fleisher","year":"2014","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0045|ecc12787-cit-0045","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.breast.2010.03.008","article-title":"Osteonecrosis of the jaw (ONJ) risk in breast cancer patients after zoledronic acid treatment","volume":"19","author":"Fusco","year":"2010","journal-title":"Breast"},{"key":"10.1111\/ecc.12787-BIB0046|ecc12787-cit-0046","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S1470-2045(11)70122-X","article-title":"Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial","volume":"12","author":"Gnant","year":"2011","journal-title":"Lancet Oncology"},{"key":"10.1111\/ecc.12787-BIB0047|ecc12787-cit-0047","first-page":"1391","article-title":"Bisphosphonate-associated osteonecrosis of the jaw 2\u00a0years after teeth extractions: A case report solved with non-invasive treatment","volume":"18","author":"Gomez-Moreno","year":"2014","journal-title":"European Review for Medical and Pharmacological Sciences"},{"key":"10.1111\/ecc.12787-BIB0048|ecc12787-cit-0048","first-page":"1","article-title":"Treatment of bisphosphonate-related osteonecrosis of the jaw using platelet-rich fibrin","volume":"35","author":"Gonen","year":"2016","journal-title":"Cranio"},{"key":"10.1111\/ecc.12787-BIB0049|ecc12787-cit-0049","doi-asserted-by":"crossref","first-page":"1669","DOI":"10.1007\/s00256-014-1951-1","article-title":"Cone beam computed tomography for diagnosis of bisphosphonate-related osteonecrosis of the jaw: Evaluation of quantitative and qualitative image parameters","volume":"43","author":"Guggenberger","year":"2014","journal-title":"Skeletal Radiology"},{"key":"10.1111\/ecc.12787-BIB0050|ecc12787-cit-0050","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/ol.2015.3156","article-title":"Effect of the cumulative dose of zoledronic acid on the pathogenesis of osteonecrosis of the jaws","volume":"10","author":"Gunaldi","year":"2015","journal-title":"Oncology Letters"},{"key":"10.1111\/ecc.12787-BIB0051|ecc12787-cit-0051","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.jcms.2014.01.012","article-title":"A simple evaluation method for early detection of bisphosphonate-related osteonecrosis of the mandible using computed tomography","volume":"42","author":"Hamada","year":"2014","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0052|ecc12787-cit-0052","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.joms.2014.07.012","article-title":"Temporal correlation between bisphosphonate termination and symptom resolution in osteonecrosis of the jaw: A pooled case report analysis","volume":"73","author":"Hinson","year":"2015","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0053|ecc12787-cit-0053","doi-asserted-by":"crossref","first-page":"452737","DOI":"10.1155\/2014\/452737","article-title":"Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary","volume":"2014","author":"Hinson","year":"2014","journal-title":"International Journal of Dentistry"},{"key":"10.1111\/ecc.12787-BIB0054|ecc12787-cit-0054","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00784-014-1273-7","article-title":"Macrophages and bisphosphonate-related osteonecrosis of the jaw (BRONJ): Evidence of local immunosuppression of macrophages in contrast to other infectious jaw diseases","volume":"19","author":"Hoefert","year":"2015","journal-title":"Clinical Oral Investigations"},{"key":"10.1111\/ecc.12787-BIB0055|ecc12787-cit-0055","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bone.2014.12.021","article-title":"Successful treatment of bisphosphonate-related osteonecrosis of the jaw (BRONJ) patients with sitafloxacin: New strategies for the treatment of BRONJ","volume":"73","author":"Ikeda","year":"2015","journal-title":"Bone"},{"key":"10.1111\/ecc.12787-BIB0056|ecc12787-cit-0056","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.joms.2008.02.012","article-title":"Nonexposed bisphosphonate-related osteonecrosis of the jaws: Another clinical variant?","volume":"66","author":"Junquera","year":"2008","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0057|ecc12787-cit-0057","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.amjoto.2008.07.014","article-title":"Clinical experiences with bisphosphonate-associated osteonecrosis of the jaws: Analysis of 21 cases","volume":"30","author":"Junquera","year":"2009","journal-title":"American Journal of Otolaryngology"},{"key":"10.1111\/ecc.12787-BIB0058|ecc12787-cit-0058","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1248\/bpb.b15-00385","article-title":"Incidence and risk factors of osteonecrosis of the jaw in advanced cancer patients after treatment with zoledronic acid or denosumab: A retrospective cohort study","volume":"38","author":"Kajizono","year":"2015","journal-title":"Biological &\/and Pharmaceutical Bulletin"},{"key":"10.1111\/ecc.12787-BIB0059|ecc12787-cit-0059","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.ijom.2015.07.018","article-title":"Administration of teriparatide improves the symptoms of advanced bisphosphonate-related osteonecrosis of the jaw: Preliminary findings","volume":"44","author":"Kakehashi","year":"2015","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0060|ecc12787-cit-0060","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12967-015-0568-z","article-title":"Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw","volume":"13","author":"Kalyan","year":"2015","journal-title":"Journal of Translational Medicine"},{"key":"10.1111\/ecc.12787-BIB0061|ecc12787-cit-0061","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.oooo.2015.11.012","article-title":"Surgical evaluation of panoramic radiography and cone beam computed tomography for therapy planning of bisphosphonate-related osteonecrosis of the jaws","volume":"121","author":"Kammerer","year":"2016","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"key":"10.1111\/ecc.12787-BIB0062|ecc12787-cit-0062","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/jop.12419","article-title":"Modified protocol including topical minocycline in orabase to manage medication-related osteonecrosis of the jaw cases","volume":"45","author":"Karasneh","year":"2016","journal-title":"Journal of Oral Pathology and Medicine"},{"key":"10.1111\/ecc.12787-BIB0063|ecc12787-cit-0063","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","article-title":"Diagnosis and management of osteonecrosis of the jaw: A systematic review and international consensus","volume":"30","author":"Khan","year":"2015","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/ecc.12787-BIB0064|ecc12787-cit-0064","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jocd.2016.09.005","article-title":"Case-based review of osteonecrosis of the jaw (ONJ) and application of the international recommendations for management from the international task force on ONJ","volume":"20","author":"Khan","year":"2017","journal-title":"Journal of Clinical Densitometry"},{"key":"10.1111\/ecc.12787-BIB0065|ecc12787-cit-0065","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bjoms.2014.07.256","article-title":"Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: A prospective feasibility study","volume":"52","author":"Kim","year":"2014","journal-title":"British Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0066|ecc12787-cit-0066","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1563\/aaid-joi-D-14-00309","article-title":"Simultaneous application of bone morphogenetic Protein-2 and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of jaw","volume":"42","author":"Kim","year":"2016","journal-title":"European Journal of Oral Implantology"},{"key":"10.1111\/ecc.12787-BIB0067|ecc12787-cit-0067","doi-asserted-by":"crossref","first-page":"206","DOI":"10.5125\/jkaoms.2014.40.5.206","article-title":"Drug holiday as a prognostic factor of medication-related osteonecrosis of the jaw","volume":"40","author":"Kim","year":"2014","journal-title":"Journal of the Korean Association of Oral and Maxillofacial Surgeons"},{"key":"10.1111\/ecc.12787-BIB0068|ecc12787-cit-0068","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1007\/s00198-014-2622-8","article-title":"Distinctive role of 6-month teriparatide treatment on intractable bisphosphonate-related osteonecrosis of the jaw","volume":"25","author":"Kim","year":"2014","journal-title":"Osteoporosis International"},{"key":"10.1111\/ecc.12787-BIB0069|ecc12787-cit-0069","doi-asserted-by":"crossref","first-page":"193","DOI":"10.5125\/jkaoms.2016.42.4.193","article-title":"Evaluation of the predisposing factors and involved outcome of surgical treatment in bisphosphonate-related osteonecrosis of the jaw cases including bone biopsies","volume":"42","author":"Kim","year":"2016","journal-title":"Journal of the Korean Association of Oral and Maxillofacial Surgeons"},{"key":"10.1111\/ecc.12787-BIB0070|ecc12787-cit-0070","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1016\/j.jcms.2016.08.001","article-title":"Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws","volume":"44","author":"Klingelhoffer","year":"2016","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0071|ecc12787-cit-0071","doi-asserted-by":"crossref","first-page":"117","DOI":"10.5114\/aoms.2014.40738","article-title":"Association of dental and periodontal status with bisphosphonate-related osteonecrosis of the jaws. A retrospective case controlled study","volume":"10","author":"Kos","year":"2014","journal-title":"Archives of Medical Science"},{"key":"10.1111\/ecc.12787-BIB0072|ecc12787-cit-0072","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5114\/aoms.2015.50964","article-title":"Incidence and risk predictors for osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates","volume":"11","author":"Kos","year":"2015","journal-title":"Archives of Medical Science"},{"key":"10.1111\/ecc.12787-BIB0073|ecc12787-cit-0073","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.oraloncology.2012.03.028","article-title":"Bisphosphonate-related osteonecrosis of the jaws-A review","volume":"48","author":"Kuhl","year":"2012","journal-title":"Oral Oncology"},{"key":"10.1111\/ecc.12787-BIB0074|ecc12787-cit-0074","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s00198-010-1177-6","article-title":"Denosumab-related osteonecrosis of the jaws","volume":"22","author":"Kyrgidis","year":"2011","journal-title":"Osteoporosis International"},{"key":"10.1111\/ecc.12787-BIB0075|ecc12787-cit-0075","doi-asserted-by":"crossref","first-page":"4634","DOI":"10.1200\/JCO.2008.16.2768","article-title":"Bisphosphonate-related osteonecrosis of the jaws: A case-control study of risk factors in breast cancer patients","volume":"26","author":"Kyrgidis","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1111\/ecc.12787-BIB0076|ecc12787-cit-0076","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00520-008-0484-3","article-title":"Osteonecrosis of the jaw (ONJ) in cancer patients treated with Bisphosphonates: How the knowledge of a phenomenon can change its evolution","volume":"16","author":"Verde","year":"2008","journal-title":"Supportive Care in Cancer"},{"key":"10.1111\/ecc.12787-BIB0077|ecc12787-cit-0077","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jfma.2012.04.010","article-title":"Clinical treatment outcomes for 40 patients with bisphosphonates-related osteonecrosis of the jaws","volume":"113","author":"Lee","year":"2014","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1111\/ecc.12787-BIB0078|ecc12787-cit-0078","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/298945","article-title":"Platelet rich plasma in the treatment of bisphosphonate-related osteonecrosis of the jaw: Personal experience and review of the literature","author":"Longo","year":"2014","journal-title":"International Journal of Dentistry"},{"key":"10.1111\/ecc.12787-BIB0079|ecc12787-cit-0079","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1016\/j.joms.2013.08.023","article-title":"Exposed bone in bisphosphonate-related osteonecrosis of the jaws may be induced and maintained by localized microbial biofilm osteomyelitis","volume":"71","author":"Lumerman","year":"2013","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0080|ecc12787-cit-0080","doi-asserted-by":"crossref","first-page":"e444","DOI":"10.4317\/jced.52234","article-title":"Jaw osteonecrosis management around a dental implant inserted 2\u00a0years before starting treatment with zoledronic acid","volume":"7","author":"Marin-Fernandez","year":"2015","journal-title":"Journal of Clinical and Experimental Dentistry"},{"key":"10.1111\/ecc.12787-BIB0081|ecc12787-cit-0081","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","article-title":"Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: A growing epidemic","volume":"61","author":"Marx","year":"2003","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0082|ecc12787-cit-0082","doi-asserted-by":"crossref","first-page":"427273","DOI":"10.1155\/2014\/427273","article-title":"Conservative treatment of bisphosphonate-related osteonecrosis of the jaw in multiple myeloma patients","volume":"2014","author":"Melea","year":"2014","journal-title":"International Journal of Dentistry"},{"key":"10.1111\/ecc.12787-BIB0083|ecc12787-cit-0083","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.ijom.2015.05.002","article-title":"Clinical utility of three-dimensional SPECT\/CT imaging as a guide for the resection of medication-related osteonecrosis of the jaw","volume":"44","author":"Miyashita","year":"2015","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0084|ecc12787-cit-0084","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.jcms.2016.07.026","article-title":"Prevention of bisphosphonate-related osteonecrosis of the jaws in patients with prostate cancer treated with zoledronic acid - A prospective study over 6\u00a0years","volume":"44","author":"Mucke","year":"2016","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0085|ecc12787-cit-0085","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/s00223-014-9858-3","article-title":"Teriparatide therapy for denosumab-induced osteonecrosis of the jaw in a male osteoporotic patient","volume":"95","author":"Neuprez","year":"2014","journal-title":"Calcified Tissue International"},{"key":"10.1111\/ecc.12787-BIB0086|ecc12787-cit-0086","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jpor.2014.08.001","article-title":"Osteonecrosis of the jaw in patients with dental prostheses being treated with bisphosphonates or denosumab","volume":"59","author":"Niibe","year":"2015","journal-title":"Journal of Prosthodontic Research"},{"key":"10.1111\/ecc.12787-BIB0087|ecc12787-cit-0087","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.ijom.2015.01.014","article-title":"Risk factors influencing BRONJ staging in patients receiving intravenous bisphosphonates: A multivariate analysis","volume":"44","author":"Nisi","year":"2015","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0088|ecc12787-cit-0088","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1016\/j.ijom.2016.04.010","article-title":"Surgical treatment of osteonecrosis of the jaw with the use of platelet-rich fibrin: A prospective study of 15 patients","volume":"45","author":"Norholt","year":"2016","journal-title":"International Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0089|ecc12787-cit-0089","first-page":"3707","article-title":"Osteonecrosis of the jaw in patient with denosumab therapy","volume":"7","author":"Olate","year":"2014","journal-title":"International Journal of Clinical and Experimental Medicine"},{"key":"10.1111\/ecc.12787-BIB0090|ecc12787-cit-0090","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.jcms.2013.05.038","article-title":"Successful surgical management of osteonecrosis of the jaw due to RANK-ligand inhibitor treatment using fluorescence guided bone resection","volume":"41","author":"Otto","year":"2013","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"},{"key":"10.1111\/ecc.12787-BIB0091|ecc12787-cit-0091","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1359\/jbmr.2004.19.1.147","article-title":"The nitrogen-containing bisphosphonate, zoledronic acid, influences RANKL expression in human osteoblast-like cells by activating TNF-alpha converting enzyme (TACE)","volume":"19","author":"Pan","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1111\/ecc.12787-BIB0092|ecc12787-cit-0092","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/j.1601-0825.2012.01911.x","article-title":"Non-exposed bisphosphonate-related osteonecrosis of the jaw: A critical assessment of current definition, staging, and treatment guidelines","volume":"18","author":"Patel","year":"2012","journal-title":"Oral Diseases"},{"key":"10.1111\/ecc.12787-BIB0093|ecc12787-cit-0093","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1093\/jnci\/djq516","article-title":"Osteonecrosis of the jaw and the role of macrophages","volume":"103","author":"Pazianas","year":"2011","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1111\/ecc.12787-BIB0094|ecc12787-cit-0094","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1177\/0022034514560768","article-title":"Diabetes as a risk factor for medication-related osteonecrosis of the jaw","volume":"94","author":"Peer","year":"2015","journal-title":"Journal of Dental Research"},{"key":"10.1111\/ecc.12787-BIB0095|ecc12787-cit-0095","doi-asserted-by":"crossref","first-page":"e320","DOI":"10.4317\/medoral.19458","article-title":"Alternative treatments for oral bisphosphonate-related osteonecrosis of the jaws: A pilot study comparing fibrin rich in growth factors and teriparatide","volume":"19","author":"Pelaz","year":"2014","journal-title":"Medicina Oral, Patolog\u00eda Oral y Cirug\u00eda Bucal"},{"key":"10.1111\/ecc.12787-BIB0096|ecc12787-cit-0096","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.3324\/haematol.11096","article-title":"Role of ozone therapy in the treatment of osteonecrosis of the jaws in multiple myeloma patients","volume":"92","author":"Petrucci","year":"2007","journal-title":"Haematologica"},{"key":"10.1111\/ecc.12787-BIB0097|ecc12787-cit-0097","doi-asserted-by":"crossref","first-page":"e671","DOI":"10.1097\/MD.0000000000000671","article-title":"Is administration of trastuzumab an independent risk factor for developing osteonecrosis of the jaw among metastatic breast cancer patients under zoledronic acid treatment?","volume":"94","author":"Pilanci","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1111\/ecc.12787-BIB0098|ecc12787-cit-0098","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/j.oooo.2014.04.014","article-title":"Doxycycline fluorescence-guided Er: YAG laser ablation combined with Nd:YAG\/diode laser biostimulation for treating bisphosphonate-related osteonecrosis of the jaw","volume":"119","author":"Porcaro","year":"2015","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology"},{"key":"10.1111\/ecc.12787-BIB0099|ecc12787-cit-0099","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1177\/1049909114539035","article-title":"Palliative oncology: Denosumab","volume":"32","author":"Prommer","year":"2015","journal-title":"The American Journal of Hospice & Palliative Care"},{"key":"10.1111\/ecc.12787-BIB0100|ecc12787-cit-0100","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/ijos.2014.46","article-title":"Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw","volume":"6","author":"Pushalkar","year":"2014","journal-title":"International Journal of Dentistry and Oral Science"},{"key":"10.1111\/ecc.12787-BIB0101|ecc12787-cit-0101","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10147-013-0561-6","article-title":"Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: A meta-analysis of seven randomized controlled trials","volume":"19","author":"Qi","year":"2014","journal-title":"International Journal of Clinical Oncology"},{"key":"10.1111\/ecc.12787-BIB0102|ecc12787-cit-0102","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.oraloncology.2011.01.002","article-title":"Efficacy and safety of medical ozone (O(3)) delivered in oil suspension applications for the treatment of osteonecrosis of the jaw in patients with bone metastases treated with bisphosphonates: Preliminary results of a phase I-II study","volume":"47","author":"Ripamonti","year":"2011","journal-title":"Oral Oncology"},{"key":"10.1111\/ecc.12787-BIB0103|ecc12787-cit-0103","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.jbo.2012.08.001","article-title":"Efficacy and tolerability of medical ozone gas insufflations in patients with osteonecrosis of the jaw treated with bisphosphonates-Preliminary data: Medical ozone gas insufflation in treating ONJ lesions","volume":"1","author":"Ripamonti","year":"2012","journal-title":"Journal of Bone Oncology"},{"key":"10.1111\/ecc.12787-BIB0104|ecc12787-cit-0104","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","article-title":"Molecular mechanisms of action of bisphosphonates: Current status","volume":"12","author":"Roelofs","year":"2006","journal-title":"Clinical Cancer Research"},{"key":"10.1111\/ecc.12787-BIB0105|ecc12787-cit-0105","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.joms.2014.09.023","article-title":"Pedicled buccal fat pad flap as a reliable surgical strategy for the treatment of medication-related osteonecrosis of the jaw","volume":"73","author":"Rotaru","year":"2015","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0106|ecc12787-cit-0106","first-page":"2","article-title":"American association of oral and maxillofacial surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update","volume":"67","author":"Ruggiero","year":"2009","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0107|ecc12787-cit-0107","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","article-title":"American association of oral and maxillofacial surgeons position paper on medication-related osteonecrosis of the jaw-2014 update","volume":"72","author":"Ruggiero","year":"2014","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0108|ecc12787-cit-0108","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.joms.2015.09.024","article-title":"Disease Stage and Mode of Therapy Are Important Determinants of Treatment Outcomes for Medication-Related Osteonecrosis of the Jaw","volume":"73","author":"Ruggiero","year":"2015","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0109|ecc12787-cit-0109","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.oraloncology.2014.08.016","article-title":"A systematic review of therapeutical approaches in bisphosphonates-related osteonecrosis of the jaw (BRONJ)","volume":"50","author":"Rupel","year":"2014","journal-title":"Oral Oncology"},{"key":"10.1111\/ecc.12787-BIB0110|ecc12787-cit-0110","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: Similarities and differences and their potential influence on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporosis International"},{"key":"10.1111\/ecc.12787-BIB0111|ecc12787-cit-0111","doi-asserted-by":"crossref","first-page":"31604","DOI":"10.1038\/srep31604","article-title":"The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection","volume":"6","author":"Russmueller","year":"2016","journal-title":"Scientific Reports"},{"key":"10.1111\/ecc.12787-BIB0112|ecc12787-cit-0112","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1093\/annonc\/mdr435","article-title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: Integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","volume":"23","author":"Saad","year":"2012","journal-title":"Annals of Oncology"},{"key":"10.1111\/ecc.12787-BIB0113|ecc12787-cit-0113","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.oooo.2013.02.001","article-title":"Osteonecrosis of the mandible associated with bevacizumab therapy","volume":"115","author":"Santos-Silva","year":"2013","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology And Oral Radiology"},{"key":"10.1111\/ecc.12787-BIB0114|ecc12787-cit-0114","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1182\/blood-2008-04-147884","article-title":"Bisphosphonate-related osteonecrosis of the jaw is associated with polymorphisms of the cytochrome P450 CYP2C8 in multiple myeloma: A genome-wide single nucleotide polymorphism analysis","volume":"112","author":"Sarasquete","year":"2008","journal-title":"Blood"},{"key":"10.1111\/ecc.12787-BIB0115|ecc12787-cit-0115","first-page":"6647","volume":"5","author":"Schieferdecker","year":"2014","journal-title":"Denosumab mimics the natural decoy receptor osteoprotegerin by interacting with its major binding site on RANKL Oncotarget"},{"key":"10.1111\/ecc.12787-BIB0116|ecc12787-cit-0116","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.oooo.2013.10.010","article-title":"Comparison of nonexposed and exposed bisphosphonate-induced osteonecrosis of the jaws: A retrospective analysis from the Copenhagen cohort and a proposal for an updated classification system","volume":"117","author":"Schiodt","year":"2014","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology And Oral Radiology"},{"key":"10.1111\/ecc.12787-BIB0117|ecc12787-cit-0117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.reuma.2012.06.007","article-title":"Denosumab for the treatment of osteoporosis: A systematic literature review","volume":"9","author":"Silva-Fernandez","year":"2013","journal-title":"Reumatolog\u00eda Clinica"},{"key":"10.1111\/ecc.12787-BIB0118|ecc12787-cit-0118","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.joms.2013.07.027","article-title":"Management of bisphosphonate-related osteonecrosis of the jaw with a platelet-rich fibrin membrane: Technical report","volume":"72","author":"Soydan","year":"2014","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0119|ecc12787-cit-0119","first-page":"1299","article-title":"The outcome after surgical therapy of bisphosphonate-associated osteonecrosis of the jaw-results of a clinical case series with an average follow-up of 20\u00a0months","volume":"18","author":"Stockmann","year":"2014","journal-title":"Clinical Oral Investigation"},{"key":"10.1111\/ecc.12787-BIB0120|ecc12787-cit-0120","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00520-015-2904-5","article-title":"Safety of long-term denosumab therapy: Results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer","volume":"24","author":"Stopeck","year":"2016","journal-title":"Supportive Care in Cancer"},{"key":"10.1111\/ecc.12787-BIB0121|ecc12787-cit-0121","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S1470-2045(10)70010-3","article-title":"Denosumab in patients with giant-cell tumour of bone: An open-label, phase 2 study","volume":"11","author":"Thomas","year":"2010","journal-title":"Lancet Oncology"},{"key":"10.1111\/ecc.12787-BIB0122|ecc12787-cit-0122","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00784-015-1563-8","article-title":"Bone scintigraphy predicts bisphosphonate-induced osteonecrosis of the jaw (BRONJ) in patients with metastatic castration-resistant prostate cancer (mCRPC)","volume":"20","author":"Thomas","year":"2016","journal-title":"Clinical Oral Investigation"},{"key":"10.1111\/ecc.12787-BIB0123|ecc12787-cit-0123","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.jfma.2015.10.005","article-title":"Treatment of bisphosphonate-related osteonecrosis of the jaw with platelet-rich fibrin","volume":"115","author":"Tsai","year":"2016","journal-title":"Journal of the Formosan Medical Association"},{"key":"10.1111\/ecc.12787-BIB0124|ecc12787-cit-0124","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/SCS.0000000000001665","article-title":"Tooth extractions in high-risk patients under bisphosphonate therapy and previously affected with osteonecrosis of the jaws: Surgical protocol supported by low-level laser therapy","volume":"26","author":"Vescovi","year":"2015","journal-title":"The Journal of Craniofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0125|ecc12787-cit-0125","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1089\/pho.2015.3927","article-title":"Medication-related osteonecrosis of the jaw: An autofluorescence-guided surgical approach performed with Er:YAG laser","volume":"33","author":"Vescovi","year":"2015","journal-title":"Photomedicine and Laser Surgery"},{"key":"10.1111\/ecc.12787-BIB0126|ecc12787-cit-0126","doi-asserted-by":"crossref","first-page":"107690","DOI":"10.1155\/2014\/107690","article-title":"Conservative surgical management of stage I bisphosphonate-related osteonecrosis of the jaw","volume":"2014","author":"Vescovi","year":"2014","journal-title":"International Journal of Dentistry"},{"key":"10.1111\/ecc.12787-BIB0127|ecc12787-cit-0127","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1007\/s12149-016-1145-0","article-title":"Bone scan index of the jaw: A new approach for evaluating early-stage anti-resorptive agents-related osteonecrosis","volume":"31","author":"Watanabe","year":"2017","journal-title":"Annals of Nuclear Medicine"},{"key":"10.1111\/ecc.12787-BIB0128|ecc12787-cit-0128","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s10103-016-1929-4","article-title":"Efficacy of laser therapy in the management of bisphosphonate-related osteonecrosis of the jaw (BRONJ): A systematic review","volume":"31","author":"Weber","year":"2016","journal-title":"Lasers in Medical Science"},{"key":"10.1111\/ecc.12787-BIB0129|ecc12787-cit-0129","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.joms.2007.11.032","article-title":"Zoledronate, smoking, and obesity are strong risk factors for osteonecrosis of the jaw: A case-control study","volume":"66","author":"Wessel","year":"2008","journal-title":"Journal of Oral and Maxillofacial Surgery"},{"key":"10.1111\/ecc.12787-BIB0130|ecc12787-cit-0130","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.oooo.2014.12.024","article-title":"Dentoalveolar trauma and minor trauma as precipitating factors for medication-related osteonecrosis of the jaw (ONJ): A retrospective study of 149 consecutive patients from the Copenhagen ONJ Cohort","volume":"119","author":"Yazdi","year":"2015","journal-title":"Oral Surgery, Oral Medicine, Oral Pathology And Oral Radiology"},{"key":"10.1111\/ecc.12787-BIB0131|ecc12787-cit-0131","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/j.1349-7006.2008.00803.x","article-title":"Phase 1 trial of denosumab safety, pharmacokinetics, and pharmacodynamics in Japanese women with breast cancer-related bone metastases","volume":"99","author":"Yonemori","year":"2008","journal-title":"Cancer Science"},{"key":"10.1111\/ecc.12787-BIB0132|ecc12787-cit-0132","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.4317\/jced.51213","article-title":"Prognosis factors in the treatment of bisphosphonate-related osteonecrosis of the jaw-Prognostic factors in the treatment of BRONJ","volume":"6","author":"Yoshiga","year":"2014","journal-title":"Journal of Clinical and Experimental Dentistry"},{"key":"10.1111\/ecc.12787-BIB0133|ecc12787-cit-0133","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/s00198-015-3096-z","article-title":"Intraoperative detection of viable bone with fluorescence imaging using visually enhanced lesion scope in patients with bisphosphonate-related osteonecrosis of the jaw: Clinical and pathological evaluation","volume":"26","author":"Yoshiga","year":"2015","journal-title":"Osteoporosis International"},{"key":"10.1111\/ecc.12787-BIB0134|ecc12787-cit-0134","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.jcms.2015.08.008","article-title":"Perioperative discontinuation of intravenous bisphosphonate therapy reduces the incidence and severity of bisphosphonate-related osteonecrosis of the jaw: A randomized, controlled, prospective experimental study in rats","volume":"43","author":"Zandi","year":"2015","journal-title":"Journal of Cranio-Maxillo-Facial Surgery"}],"container-title":["European Journal of Cancer Care"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fecc.12787","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/ecc.12787\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T13:10:45Z","timestamp":1671541845000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ecc.12787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10,24]]},"references-count":134,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"URL":"https:\/\/doi.org\/10.1111\/ecc.12787","archive":["Portico"],"relation":{},"ISSN":["0961-5423"],"issn-type":[{"value":"0961-5423","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10,24]]}}}